The importance of RAS/Ang II in connection between blood pressure and AAA in humans is supported by clinical trials data where blood pressure-reducing medications targeting RAS/Ang II circuit significantly decreases the incidence of aortic dissection9. This evidence concerns the gene AGT and triple-A syndrome.